Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Effect of Transcranial Near Infrared Light 1068 nm Upon Memory Performance in Ageing Healthy Individuals: a Pilot Study.
Authors not listed
Maculume Ltd. · 2017
Abstract
A double-blind placebo-controlled study evaluating the effect of 1068nm NIR trans-cranial phototherapy upon the cognitive function of healthy individuals between the age of 45 years and 80 years.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2017). Effect of Transcranial Near Infrared Light 1068 nm Upon Memory Performance in Ageing Healthy Individuals: a Pilot Study. <em>Maculume Ltd.</em>. https://clinicaltrials.gov/study/NCT04568057
Vancouver
Anonymous. Effect of Transcranial Near Infrared Light 1068 nm Upon Memory Performance in Ageing Healthy Individuals: a Pilot Study. Maculume Ltd.. 2017.
BibTeX
@misc{anon2017Effect,
title = {Effect of Transcranial Near Infrared Light 1068 nm Upon Memory Performance in Ageing Healthy Individuals: a Pilot Study.},
author = {Anonymous},
journal = {Maculume Ltd.},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Abyss Ingredients 2021
Open access · US-GOV
Evaluation of the Effect of Peptides and n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) From a Blue Fish Hydrolysate on Memory in Healthy Elderly People : a Randomised, Placebo-controlled, Double-blind Study.
Acta Neuropathologica 2003
Citation only
α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study
Maturitas 2024
Open access · OA
Healthy aging among centenarians and near-centenarians: Findings from the Georgia Centenarian Study
Scientific reports 2025
Open access · OA
Targeting biological age with bioactive, microbiota-accessible nutritional complexes: a pilot study on healthspan extension in medically healthy adults.
CanSino Biologics Inc. 2020
Open access · US-GOV
A Randomized, Observer-Blind, Dose-escalation Phase I/II Clinical Trial of Ad5-nCoV Vaccine in Healthy Adults From 18 to <85 Years of Age in Canada
University of Kansas Medical Center 2025
Open access · US-GOV